Newsbenzinga
HUTCHMED's Experimental Drug Shows Durable Responses In Advanced Bile Duct Cancer Trial
· Published
Article summary
HUTCHMED reported positive Phase 2 data for fanregratinib in advanced ICC as China reviews the drug.
An excerpt from the original article.
Comments —
Loading comments…